Please login to the form below

Not currently logged in
Email:
Password:

Lonza appoints pharma COO

Marc Funk replaces Stephan Kutzer

Marc Funk LonzaSwiss life sciences firm Lonza has announced that Stephan Kutzer is to step down as chief operations officer for its pharma and biotech division to be replaced by Marc Funk.

Funk, who is currently the company's chief legal officer, will take over from Kutzer on July 1, 2014.

Richard Ridinger, CEO of Lonza, said: “[Funk] has already successfully managed operational and commercial projects in the pharma and biotech network and has been responsible for global quality in pharma & biotech for more than a year.”

Funk's experience prior to joining Lonza in 2008 includes four years as corporate counsel at Merck Serono.

He was also previously a co-CEO at GeneProt, a now defunct US-based biotech company.

29th April 2014

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Syneos Health®

Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and...

Latest intelligence

Article:
The disparity of patient experiences with Crohn’s Disease in Europe and Japan...
Patient diversity in clinical trials
The pursuit of patient diversity in clinical trials
When all-inclusive isn’t an option, it’s an obligation...
Overcoming the digital patient recruitment challenges of connecting with patients
How many irrelevant experiences, ads, emails, direct messages have you rejected this week?...